Given A2's conservative reporting in the past, I think we can expect the expected AR of $300-313m and EBDITA of $33-37m, anywhere between that and i'll be very satisfied, given 2015 was $155m and $4.8m. That's quite significant growth in my opinion.
Hopefully they have a fairly rigorous plan in place to combat the supply side, which I think they will.
- Forums
- ASX - By Stock
- A2M
- Strong Technical Analysis Sees $2.2 - $2.4 SP
Strong Technical Analysis Sees $2.2 - $2.4 SP, page-51
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.78 |
Change
-0.140(2.85%) |
Mkt cap ! $3.489B |
Open | High | Low | Value | Volume |
$4.95 | $4.95 | $4.77 | $22.84M | 4.739M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 5269 | $4.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.79 | 29370 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 4823 | 4.780 |
32 | 61304 | 4.770 |
15 | 39337 | 4.760 |
17 | 43301 | 4.750 |
7 | 37026 | 4.740 |
Price($) | Vol. | No. |
---|---|---|
4.790 | 29370 | 25 |
4.800 | 44057 | 12 |
4.810 | 90548 | 12 |
4.820 | 103595 | 6 |
4.830 | 4846 | 4 |
Last trade - 15.36pm 12/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online